PMID: 14392242Jul 1, 1955Paper

Studies on antibody production. III. The alum granuloma

The Journal of Experimental Medicine
R G WHITEJ M CONNOLLY

Abstract

After subcutaneous injection of hen's ovalbumin or diphtheria toxoid precipitated with aluminum phosphate, the production of antibody, as judged by the presence in the tissues of antibody-containing cells, proceeds partly within the regional lymphatic glands and partly in the granulation tissue surrounding the nodule which develops at the site of injection. The first production of antibody takes place in the regional lymphatic gland and antibody production in the local granuloma becomes apparent only from 14 days onwards (rabbit). Antibody-containing plasma cells were demonstrated in the local granuloma up to 7 weeks. Antibody-containing cells in the regional lymphatic glands reach maximum numbers at 2 weeks following injection and decrease thereafter to few cells at 5 weeks. The adjuvant effect of the aluminum phosphate is interpreted as due partly to the delay in absorption of antigen from the local site of its injection which results in prolongation of stimulation of cells within the regional lymphatic glands, and partly to the production of a local granuloma which contains antibody-producing plasma cells.

References

Jul 1, 1953·The Journal of Experimental Medicine·D L COFFINV J CABASSO
Feb 1, 1951·The Journal of Experimental Medicine·A H COONSM H KAPLAN
Mar 1, 1935·American Journal of Public Health and the Nation's Health·W T Harrison

❮ Previous
Next ❯

Citations

Apr 1, 1963·The Journal of Pathology and Bacteriology·L GOLDBERGJ P SMITH
Jan 1, 1969·Progress in Biophysics and Molecular Biology·C C Congdon
Mar 1, 1982·Journal of the Autonomic Nervous System·H HayashiH Yajima
Jan 1, 1993·Vaccine·R K GuptaC K Gupta
May 1, 1983·Brain Research Bulletin·W S GriffinM R Morrison
Jun 6, 2000·Advanced Drug Delivery Reviews·R K Gupta
Nov 15, 1958·Nature·R G WHITE
Feb 28, 2009·Nature Reviews. Immunology·Philippa MarrackMichael W Munks
Apr 1, 1961·Archives of Environmental Health·A COLLETF TOULLET
Jan 1, 1984·New Zealand Veterinary Journal·A D Ross, D M Titterington
Dec 22, 2007·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Daniel KrewskiVirginie Rondeau
Sep 1, 1965·The Journal of Cell Biology·S de Petris, G Karlsbad
Jan 1, 1995·ILAR Journal·W. Carey HanlyB. Taylor Bennett
May 1, 1981·Acta Physiologica Scandinavica·R UddmanF Sundler
Aug 1, 1982·Acta Physiologica Scandinavica·S LeanderR Uddman
Jul 1, 1978·Immunology·P Frost, E M Lance
Aug 1, 1972·Japanese Journal of Medical Science & Biology·K S Thind
Sep 5, 1958·Annals of the New York Academy of Sciences·J M YOFFEYL KELLY
Oct 16, 2007·Archives of Dermatological Research·M LaporteM Heenen
Jul 8, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luis A Brito, Derek T O'Hagan
Dec 3, 2014·Journal of Pharmaceutical Sciences·Brittany L HartwellCory Berkland
Feb 3, 2016·Trends in Immunology·Nathan D PennockRoss M Kedl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.